[
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These vesicles contain plasma membrane calcium ATPases (PMCAs) that pump Ca2+ from the cytosol into vesicles and thus protect the cytosolic and membrane proteins from Ca2+-induced damage (oxidation, proteolysis, irreversible dehydration) (see \nFigure 2A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Regulation of Ca2+ concentrations translates into the control over the remodeling of the cytoskeletal elements and concomitant changes in cell shape, cell volume, rheological properties and ultimately, RBC longevity and clearance (52) (\n\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Defective organelle sorting and extrusion from erythroblasts leaves organellar remnants in reticulocytes.Multiple types of channels permeable for Ca2+ are present in the RBC membrane supporting versatility and plasticity of intracellular Ca2+ signaling (53) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "One of the first Ca2+ signaling processes identified in RBCs was the function of the Gárdos channel (potassium calcium-activated channel subfamily N member 4, KCNN4) (63) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Activation of KCNN4 in RBCs of healthy people most likely enables better passage of RBCs through narrow capillaries (70), while its overactivation causes Ca2+-overload and RBC dehydration (71) (\n\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "RBCs from patients with sickle cell disease carry higher numbers of NMDA receptors than in healthy donors (\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In contrast, hyperactive JAK2 signaling in PV increases free intracellular Ca2+ levels, which impairs the nuclear export function of CALR (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In mature RBCs from PV patients, high Ca2+ levels increase the activity of the Gárdos channel leading to cell dehydration (111) (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Transmembrane domain (TM), N- and C- termini are indicated. (C) Canonical BAX and BAK dependent pathway of apoptosis and the mechanism through which venetoclax inhibits this pathway. (D) Non-canonical ER Ca2+-dependent pathway of apoptosis and the mechanism through which BIRD-2 inhibits this pathway.4.2 IP3 signaling cascade and Ca2+ release from the ER\nIP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 6\n demonstrates the mutational landscape in lymphoid cancers and \nFigure 7\n in myeloid cancers.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The lymphoid neoplasms reviewed included B-ALL (n = 234-269 patients depending on the gene), DLBCL (n = 1288), low-grade B-cell neoplasms (n= 1542) including CLL (n = 1254), monoclonal B-cell lymphocytosis (n = 54), mantle cell lymphoma (n = 29), plasma cell myeloma (n= 205) and low-grade T-cell neoplasms (n = 43) including Sezary syndrome (n = 26), primary cutaneous CD8/CD30 positive lymphomas (n = 14) and mycosis fungoides (n = 3) (\nFigure 6\n, \nTable 3\n and \nSupplementary Table 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these lymphoid cancers, patients with B-ALL had the lowest frequency of variants in the Ca2+-toolkit encoding genes (5.9%) and patients with low-grade T-cell neoplasms had the highest frequency (48.8%), most carrying multiple variants (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The cBioPortal data did not yet contain results of Bohannan et al. published earlier this year that reported the presence of GRIN2C mutations in high-risk B-ALL patients (145) (\nFigure 3C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Specific genetic variants can be found through these links, all were of unknown significance. *Numbers of patients analyzed and disease groups are clarified in \nTable 3\n.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "AML, acute myeloid leukemia; B-ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; MBL, monoclonal B-cell lymphocytosis; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasms; PCM, plasma cell myeloma.In mature T-cell neoplasms, the most affected genes were those coding for PLC (16.3%), Ca2+/Na+/K+ exchangers (14.0%), TRPC and TRPM channels (11.6% each), CaV and NMDA receptor channels (9.3% each), ryanodine receptors (RYR) (7.0%), and a few others at 4.7% each (TRPV, P2RX, and SERCA) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In mature B-cell neoplasms, mutated genes were broadly similar between the low-grade and high-grade cancers (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In DLBCL, RYR mutations were less common (2.5%) but CACNA variants were more common (3.8%) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RYRs facilitate the release of Ca2+ from the ER in addition to IP3Rs (362) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the group of myeloid neoplasms, we reviewed 821 patients with AML, 151 with MPN and 31-431 patients with myelodysplastic syndrome (MDS) (depending on the gene) (\nFigure 7\n, \nTable 3\n and \nSupplementary Table S3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "It was intriguing that these variants were exclusive with CALR mutations and also appeared exclusive with each other, raising the possibility of their independent effects in MPN (\nFigure 7\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8\n provides a schematic summary of the underlying mechanisms and their consequences in blood cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Understanding how Ca2+ signaling remodels in cancer cells creates therapeutic opportunities, with the potential to spare normal cells and tailor therapies according to the underlying mechanism in different cancers/patients (\nFigure 8\n).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These vesicles contain plasma membrane calcium ATPases (PMCAs) that pump Ca2+ from the cytosol into vesicles and thus protect the cytosolic and membrane proteins from Ca2+-induced damage (oxidation, proteolysis, irreversible dehydration) (see \nFigure 2A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Regulation of Ca2+ concentrations translates into the control over the remodeling of the cytoskeletal elements and concomitant changes in cell shape, cell volume, rheological properties and ultimately, RBC longevity and clearance (52) (\n\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Defective organelle sorting and extrusion from erythroblasts leaves organellar remnants in reticulocytes.Multiple types of channels permeable for Ca2+ are present in the RBC membrane supporting versatility and plasticity of intracellular Ca2+ signaling (53) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "One of the first Ca2+ signaling processes identified in RBCs was the function of the Gárdos channel (potassium calcium-activated channel subfamily N member 4, KCNN4) (63) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Activation of KCNN4 in RBCs of healthy people most likely enables better passage of RBCs through narrow capillaries (70), while its overactivation causes Ca2+-overload and RBC dehydration (71) (\n\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "RBCs from patients with sickle cell disease carry higher numbers of NMDA receptors than in healthy donors (\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In contrast, hyperactive JAK2 signaling in PV increases free intracellular Ca2+ levels, which impairs the nuclear export function of CALR (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In mature RBCs from PV patients, high Ca2+ levels increase the activity of the Gárdos channel leading to cell dehydration (111) (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Transmembrane domain (TM), N- and C- termini are indicated. (C) Canonical BAX and BAK dependent pathway of apoptosis and the mechanism through which venetoclax inhibits this pathway. (D) Non-canonical ER Ca2+-dependent pathway of apoptosis and the mechanism through which BIRD-2 inhibits this pathway.4.2 IP3 signaling cascade and Ca2+ release from the ER\nIP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 6\n demonstrates the mutational landscape in lymphoid cancers and \nFigure 7\n in myeloid cancers.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The lymphoid neoplasms reviewed included B-ALL (n = 234-269 patients depending on the gene), DLBCL (n = 1288), low-grade B-cell neoplasms (n= 1542) including CLL (n = 1254), monoclonal B-cell lymphocytosis (n = 54), mantle cell lymphoma (n = 29), plasma cell myeloma (n= 205) and low-grade T-cell neoplasms (n = 43) including Sezary syndrome (n = 26), primary cutaneous CD8/CD30 positive lymphomas (n = 14) and mycosis fungoides (n = 3) (\nFigure 6\n, \nTable 3\n and \nSupplementary Table 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these lymphoid cancers, patients with B-ALL had the lowest frequency of variants in the Ca2+-toolkit encoding genes (5.9%) and patients with low-grade T-cell neoplasms had the highest frequency (48.8%), most carrying multiple variants (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The cBioPortal data did not yet contain results of Bohannan et al. published earlier this year that reported the presence of GRIN2C mutations in high-risk B-ALL patients (145) (\nFigure 3C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Specific genetic variants can be found through these links, all were of unknown significance. *Numbers of patients analyzed and disease groups are clarified in \nTable 3\n.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "AML, acute myeloid leukemia; B-ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; MBL, monoclonal B-cell lymphocytosis; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasms; PCM, plasma cell myeloma.In mature T-cell neoplasms, the most affected genes were those coding for PLC (16.3%), Ca2+/Na+/K+ exchangers (14.0%), TRPC and TRPM channels (11.6% each), CaV and NMDA receptor channels (9.3% each), ryanodine receptors (RYR) (7.0%), and a few others at 4.7% each (TRPV, P2RX, and SERCA) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In mature B-cell neoplasms, mutated genes were broadly similar between the low-grade and high-grade cancers (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In DLBCL, RYR mutations were less common (2.5%) but CACNA variants were more common (3.8%) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RYRs facilitate the release of Ca2+ from the ER in addition to IP3Rs (362) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the group of myeloid neoplasms, we reviewed 821 patients with AML, 151 with MPN and 31-431 patients with myelodysplastic syndrome (MDS) (depending on the gene) (\nFigure 7\n, \nTable 3\n and \nSupplementary Table S3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "It was intriguing that these variants were exclusive with CALR mutations and also appeared exclusive with each other, raising the possibility of their independent effects in MPN (\nFigure 7\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8\n provides a schematic summary of the underlying mechanisms and their consequences in blood cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Understanding how Ca2+ signaling remodels in cancer cells creates therapeutic opportunities, with the potential to spare normal cells and tailor therapies according to the underlying mechanism in different cancers/patients (\nFigure 8\n).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These vesicles contain plasma membrane calcium ATPases (PMCAs) that pump Ca2+ from the cytosol into vesicles and thus protect the cytosolic and membrane proteins from Ca2+-induced damage (oxidation, proteolysis, irreversible dehydration) (see \nFigure 2A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Regulation of Ca2+ concentrations translates into the control over the remodeling of the cytoskeletal elements and concomitant changes in cell shape, cell volume, rheological properties and ultimately, RBC longevity and clearance (52) (\n\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Defective organelle sorting and extrusion from erythroblasts leaves organellar remnants in reticulocytes.Multiple types of channels permeable for Ca2+ are present in the RBC membrane supporting versatility and plasticity of intracellular Ca2+ signaling (53) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "One of the first Ca2+ signaling processes identified in RBCs was the function of the Gárdos channel (potassium calcium-activated channel subfamily N member 4, KCNN4) (63) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Activation of KCNN4 in RBCs of healthy people most likely enables better passage of RBCs through narrow capillaries (70), while its overactivation causes Ca2+-overload and RBC dehydration (71) (\n\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "RBCs from patients with sickle cell disease carry higher numbers of NMDA receptors than in healthy donors (\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In contrast, hyperactive JAK2 signaling in PV increases free intracellular Ca2+ levels, which impairs the nuclear export function of CALR (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In mature RBCs from PV patients, high Ca2+ levels increase the activity of the Gárdos channel leading to cell dehydration (111) (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Transmembrane domain (TM), N- and C- termini are indicated. (C) Canonical BAX and BAK dependent pathway of apoptosis and the mechanism through which venetoclax inhibits this pathway. (D) Non-canonical ER Ca2+-dependent pathway of apoptosis and the mechanism through which BIRD-2 inhibits this pathway.4.2 IP3 signaling cascade and Ca2+ release from the ER\nIP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 6\n demonstrates the mutational landscape in lymphoid cancers and \nFigure 7\n in myeloid cancers.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The lymphoid neoplasms reviewed included B-ALL (n = 234-269 patients depending on the gene), DLBCL (n = 1288), low-grade B-cell neoplasms (n= 1542) including CLL (n = 1254), monoclonal B-cell lymphocytosis (n = 54), mantle cell lymphoma (n = 29), plasma cell myeloma (n= 205) and low-grade T-cell neoplasms (n = 43) including Sezary syndrome (n = 26), primary cutaneous CD8/CD30 positive lymphomas (n = 14) and mycosis fungoides (n = 3) (\nFigure 6\n, \nTable 3\n and \nSupplementary Table 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these lymphoid cancers, patients with B-ALL had the lowest frequency of variants in the Ca2+-toolkit encoding genes (5.9%) and patients with low-grade T-cell neoplasms had the highest frequency (48.8%), most carrying multiple variants (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The cBioPortal data did not yet contain results of Bohannan et al. published earlier this year that reported the presence of GRIN2C mutations in high-risk B-ALL patients (145) (\nFigure 3C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Specific genetic variants can be found through these links, all were of unknown significance. *Numbers of patients analyzed and disease groups are clarified in \nTable 3\n.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "AML, acute myeloid leukemia; B-ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; MBL, monoclonal B-cell lymphocytosis; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasms; PCM, plasma cell myeloma.In mature T-cell neoplasms, the most affected genes were those coding for PLC (16.3%), Ca2+/Na+/K+ exchangers (14.0%), TRPC and TRPM channels (11.6% each), CaV and NMDA receptor channels (9.3% each), ryanodine receptors (RYR) (7.0%), and a few others at 4.7% each (TRPV, P2RX, and SERCA) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In mature B-cell neoplasms, mutated genes were broadly similar between the low-grade and high-grade cancers (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In DLBCL, RYR mutations were less common (2.5%) but CACNA variants were more common (3.8%) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RYRs facilitate the release of Ca2+ from the ER in addition to IP3Rs (362) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the group of myeloid neoplasms, we reviewed 821 patients with AML, 151 with MPN and 31-431 patients with myelodysplastic syndrome (MDS) (depending on the gene) (\nFigure 7\n, \nTable 3\n and \nSupplementary Table S3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "It was intriguing that these variants were exclusive with CALR mutations and also appeared exclusive with each other, raising the possibility of their independent effects in MPN (\nFigure 7\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8\n provides a schematic summary of the underlying mechanisms and their consequences in blood cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Understanding how Ca2+ signaling remodels in cancer cells creates therapeutic opportunities, with the potential to spare normal cells and tailor therapies according to the underlying mechanism in different cancers/patients (\nFigure 8\n).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These vesicles contain plasma membrane calcium ATPases (PMCAs) that pump Ca2+ from the cytosol into vesicles and thus protect the cytosolic and membrane proteins from Ca2+-induced damage (oxidation, proteolysis, irreversible dehydration) (see \nFigure 2A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Regulation of Ca2+ concentrations translates into the control over the remodeling of the cytoskeletal elements and concomitant changes in cell shape, cell volume, rheological properties and ultimately, RBC longevity and clearance (52) (\n\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Defective organelle sorting and extrusion from erythroblasts leaves organellar remnants in reticulocytes.Multiple types of channels permeable for Ca2+ are present in the RBC membrane supporting versatility and plasticity of intracellular Ca2+ signaling (53) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "One of the first Ca2+ signaling processes identified in RBCs was the function of the Gárdos channel (potassium calcium-activated channel subfamily N member 4, KCNN4) (63) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Activation of KCNN4 in RBCs of healthy people most likely enables better passage of RBCs through narrow capillaries (70), while its overactivation causes Ca2+-overload and RBC dehydration (71) (\n\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "RBCs from patients with sickle cell disease carry higher numbers of NMDA receptors than in healthy donors (\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In contrast, hyperactive JAK2 signaling in PV increases free intracellular Ca2+ levels, which impairs the nuclear export function of CALR (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In mature RBCs from PV patients, high Ca2+ levels increase the activity of the Gárdos channel leading to cell dehydration (111) (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Transmembrane domain (TM), N- and C- termini are indicated. (C) Canonical BAX and BAK dependent pathway of apoptosis and the mechanism through which venetoclax inhibits this pathway. (D) Non-canonical ER Ca2+-dependent pathway of apoptosis and the mechanism through which BIRD-2 inhibits this pathway.4.2 IP3 signaling cascade and Ca2+ release from the ER\nIP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 6\n demonstrates the mutational landscape in lymphoid cancers and \nFigure 7\n in myeloid cancers.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The lymphoid neoplasms reviewed included B-ALL (n = 234-269 patients depending on the gene), DLBCL (n = 1288), low-grade B-cell neoplasms (n= 1542) including CLL (n = 1254), monoclonal B-cell lymphocytosis (n = 54), mantle cell lymphoma (n = 29), plasma cell myeloma (n= 205) and low-grade T-cell neoplasms (n = 43) including Sezary syndrome (n = 26), primary cutaneous CD8/CD30 positive lymphomas (n = 14) and mycosis fungoides (n = 3) (\nFigure 6\n, \nTable 3\n and \nSupplementary Table 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these lymphoid cancers, patients with B-ALL had the lowest frequency of variants in the Ca2+-toolkit encoding genes (5.9%) and patients with low-grade T-cell neoplasms had the highest frequency (48.8%), most carrying multiple variants (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The cBioPortal data did not yet contain results of Bohannan et al. published earlier this year that reported the presence of GRIN2C mutations in high-risk B-ALL patients (145) (\nFigure 3C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Specific genetic variants can be found through these links, all were of unknown significance. *Numbers of patients analyzed and disease groups are clarified in \nTable 3\n.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "AML, acute myeloid leukemia; B-ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; MBL, monoclonal B-cell lymphocytosis; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasms; PCM, plasma cell myeloma.In mature T-cell neoplasms, the most affected genes were those coding for PLC (16.3%), Ca2+/Na+/K+ exchangers (14.0%), TRPC and TRPM channels (11.6% each), CaV and NMDA receptor channels (9.3% each), ryanodine receptors (RYR) (7.0%), and a few others at 4.7% each (TRPV, P2RX, and SERCA) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In mature B-cell neoplasms, mutated genes were broadly similar between the low-grade and high-grade cancers (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In DLBCL, RYR mutations were less common (2.5%) but CACNA variants were more common (3.8%) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RYRs facilitate the release of Ca2+ from the ER in addition to IP3Rs (362) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the group of myeloid neoplasms, we reviewed 821 patients with AML, 151 with MPN and 31-431 patients with myelodysplastic syndrome (MDS) (depending on the gene) (\nFigure 7\n, \nTable 3\n and \nSupplementary Table S3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "It was intriguing that these variants were exclusive with CALR mutations and also appeared exclusive with each other, raising the possibility of their independent effects in MPN (\nFigure 7\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8\n provides a schematic summary of the underlying mechanisms and their consequences in blood cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Understanding how Ca2+ signaling remodels in cancer cells creates therapeutic opportunities, with the potential to spare normal cells and tailor therapies according to the underlying mechanism in different cancers/patients (\nFigure 8\n).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These vesicles contain plasma membrane calcium ATPases (PMCAs) that pump Ca2+ from the cytosol into vesicles and thus protect the cytosolic and membrane proteins from Ca2+-induced damage (oxidation, proteolysis, irreversible dehydration) (see \nFigure 2A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Regulation of Ca2+ concentrations translates into the control over the remodeling of the cytoskeletal elements and concomitant changes in cell shape, cell volume, rheological properties and ultimately, RBC longevity and clearance (52) (\n\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Defective organelle sorting and extrusion from erythroblasts leaves organellar remnants in reticulocytes.Multiple types of channels permeable for Ca2+ are present in the RBC membrane supporting versatility and plasticity of intracellular Ca2+ signaling (53) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "One of the first Ca2+ signaling processes identified in RBCs was the function of the Gárdos channel (potassium calcium-activated channel subfamily N member 4, KCNN4) (63) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Activation of KCNN4 in RBCs of healthy people most likely enables better passage of RBCs through narrow capillaries (70), while its overactivation causes Ca2+-overload and RBC dehydration (71) (\n\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "RBCs from patients with sickle cell disease carry higher numbers of NMDA receptors than in healthy donors (\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In contrast, hyperactive JAK2 signaling in PV increases free intracellular Ca2+ levels, which impairs the nuclear export function of CALR (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In mature RBCs from PV patients, high Ca2+ levels increase the activity of the Gárdos channel leading to cell dehydration (111) (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Transmembrane domain (TM), N- and C- termini are indicated. (C) Canonical BAX and BAK dependent pathway of apoptosis and the mechanism through which venetoclax inhibits this pathway. (D) Non-canonical ER Ca2+-dependent pathway of apoptosis and the mechanism through which BIRD-2 inhibits this pathway.4.2 IP3 signaling cascade and Ca2+ release from the ER\nIP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 6\n demonstrates the mutational landscape in lymphoid cancers and \nFigure 7\n in myeloid cancers.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The lymphoid neoplasms reviewed included B-ALL (n = 234-269 patients depending on the gene), DLBCL (n = 1288), low-grade B-cell neoplasms (n= 1542) including CLL (n = 1254), monoclonal B-cell lymphocytosis (n = 54), mantle cell lymphoma (n = 29), plasma cell myeloma (n= 205) and low-grade T-cell neoplasms (n = 43) including Sezary syndrome (n = 26), primary cutaneous CD8/CD30 positive lymphomas (n = 14) and mycosis fungoides (n = 3) (\nFigure 6\n, \nTable 3\n and \nSupplementary Table 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these lymphoid cancers, patients with B-ALL had the lowest frequency of variants in the Ca2+-toolkit encoding genes (5.9%) and patients with low-grade T-cell neoplasms had the highest frequency (48.8%), most carrying multiple variants (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The cBioPortal data did not yet contain results of Bohannan et al. published earlier this year that reported the presence of GRIN2C mutations in high-risk B-ALL patients (145) (\nFigure 3C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Specific genetic variants can be found through these links, all were of unknown significance. *Numbers of patients analyzed and disease groups are clarified in \nTable 3\n.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "AML, acute myeloid leukemia; B-ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; MBL, monoclonal B-cell lymphocytosis; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasms; PCM, plasma cell myeloma.In mature T-cell neoplasms, the most affected genes were those coding for PLC (16.3%), Ca2+/Na+/K+ exchangers (14.0%), TRPC and TRPM channels (11.6% each), CaV and NMDA receptor channels (9.3% each), ryanodine receptors (RYR) (7.0%), and a few others at 4.7% each (TRPV, P2RX, and SERCA) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In mature B-cell neoplasms, mutated genes were broadly similar between the low-grade and high-grade cancers (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In DLBCL, RYR mutations were less common (2.5%) but CACNA variants were more common (3.8%) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RYRs facilitate the release of Ca2+ from the ER in addition to IP3Rs (362) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the group of myeloid neoplasms, we reviewed 821 patients with AML, 151 with MPN and 31-431 patients with myelodysplastic syndrome (MDS) (depending on the gene) (\nFigure 7\n, \nTable 3\n and \nSupplementary Table S3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "It was intriguing that these variants were exclusive with CALR mutations and also appeared exclusive with each other, raising the possibility of their independent effects in MPN (\nFigure 7\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8\n provides a schematic summary of the underlying mechanisms and their consequences in blood cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Understanding how Ca2+ signaling remodels in cancer cells creates therapeutic opportunities, with the potential to spare normal cells and tailor therapies according to the underlying mechanism in different cancers/patients (\nFigure 8\n).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These vesicles contain plasma membrane calcium ATPases (PMCAs) that pump Ca2+ from the cytosol into vesicles and thus protect the cytosolic and membrane proteins from Ca2+-induced damage (oxidation, proteolysis, irreversible dehydration) (see \nFigure 2A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Regulation of Ca2+ concentrations translates into the control over the remodeling of the cytoskeletal elements and concomitant changes in cell shape, cell volume, rheological properties and ultimately, RBC longevity and clearance (52) (\n\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Defective organelle sorting and extrusion from erythroblasts leaves organellar remnants in reticulocytes.Multiple types of channels permeable for Ca2+ are present in the RBC membrane supporting versatility and plasticity of intracellular Ca2+ signaling (53) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "One of the first Ca2+ signaling processes identified in RBCs was the function of the Gárdos channel (potassium calcium-activated channel subfamily N member 4, KCNN4) (63) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Activation of KCNN4 in RBCs of healthy people most likely enables better passage of RBCs through narrow capillaries (70), while its overactivation causes Ca2+-overload and RBC dehydration (71) (\n\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "RBCs from patients with sickle cell disease carry higher numbers of NMDA receptors than in healthy donors (\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In contrast, hyperactive JAK2 signaling in PV increases free intracellular Ca2+ levels, which impairs the nuclear export function of CALR (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In mature RBCs from PV patients, high Ca2+ levels increase the activity of the Gárdos channel leading to cell dehydration (111) (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Transmembrane domain (TM), N- and C- termini are indicated. (C) Canonical BAX and BAK dependent pathway of apoptosis and the mechanism through which venetoclax inhibits this pathway. (D) Non-canonical ER Ca2+-dependent pathway of apoptosis and the mechanism through which BIRD-2 inhibits this pathway.4.2 IP3 signaling cascade and Ca2+ release from the ER\nIP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 6\n demonstrates the mutational landscape in lymphoid cancers and \nFigure 7\n in myeloid cancers.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The lymphoid neoplasms reviewed included B-ALL (n = 234-269 patients depending on the gene), DLBCL (n = 1288), low-grade B-cell neoplasms (n= 1542) including CLL (n = 1254), monoclonal B-cell lymphocytosis (n = 54), mantle cell lymphoma (n = 29), plasma cell myeloma (n= 205) and low-grade T-cell neoplasms (n = 43) including Sezary syndrome (n = 26), primary cutaneous CD8/CD30 positive lymphomas (n = 14) and mycosis fungoides (n = 3) (\nFigure 6\n, \nTable 3\n and \nSupplementary Table 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these lymphoid cancers, patients with B-ALL had the lowest frequency of variants in the Ca2+-toolkit encoding genes (5.9%) and patients with low-grade T-cell neoplasms had the highest frequency (48.8%), most carrying multiple variants (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The cBioPortal data did not yet contain results of Bohannan et al. published earlier this year that reported the presence of GRIN2C mutations in high-risk B-ALL patients (145) (\nFigure 3C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Specific genetic variants can be found through these links, all were of unknown significance. *Numbers of patients analyzed and disease groups are clarified in \nTable 3\n.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "AML, acute myeloid leukemia; B-ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; MBL, monoclonal B-cell lymphocytosis; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasms; PCM, plasma cell myeloma.In mature T-cell neoplasms, the most affected genes were those coding for PLC (16.3%), Ca2+/Na+/K+ exchangers (14.0%), TRPC and TRPM channels (11.6% each), CaV and NMDA receptor channels (9.3% each), ryanodine receptors (RYR) (7.0%), and a few others at 4.7% each (TRPV, P2RX, and SERCA) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In mature B-cell neoplasms, mutated genes were broadly similar between the low-grade and high-grade cancers (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In DLBCL, RYR mutations were less common (2.5%) but CACNA variants were more common (3.8%) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RYRs facilitate the release of Ca2+ from the ER in addition to IP3Rs (362) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the group of myeloid neoplasms, we reviewed 821 patients with AML, 151 with MPN and 31-431 patients with myelodysplastic syndrome (MDS) (depending on the gene) (\nFigure 7\n, \nTable 3\n and \nSupplementary Table S3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "It was intriguing that these variants were exclusive with CALR mutations and also appeared exclusive with each other, raising the possibility of their independent effects in MPN (\nFigure 7\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8\n provides a schematic summary of the underlying mechanisms and their consequences in blood cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Understanding how Ca2+ signaling remodels in cancer cells creates therapeutic opportunities, with the potential to spare normal cells and tailor therapies according to the underlying mechanism in different cancers/patients (\nFigure 8\n).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These vesicles contain plasma membrane calcium ATPases (PMCAs) that pump Ca2+ from the cytosol into vesicles and thus protect the cytosolic and membrane proteins from Ca2+-induced damage (oxidation, proteolysis, irreversible dehydration) (see \nFigure 2A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Regulation of Ca2+ concentrations translates into the control over the remodeling of the cytoskeletal elements and concomitant changes in cell shape, cell volume, rheological properties and ultimately, RBC longevity and clearance (52) (\n\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Defective organelle sorting and extrusion from erythroblasts leaves organellar remnants in reticulocytes.Multiple types of channels permeable for Ca2+ are present in the RBC membrane supporting versatility and plasticity of intracellular Ca2+ signaling (53) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "One of the first Ca2+ signaling processes identified in RBCs was the function of the Gárdos channel (potassium calcium-activated channel subfamily N member 4, KCNN4) (63) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Activation of KCNN4 in RBCs of healthy people most likely enables better passage of RBCs through narrow capillaries (70), while its overactivation causes Ca2+-overload and RBC dehydration (71) (\n\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "RBCs from patients with sickle cell disease carry higher numbers of NMDA receptors than in healthy donors (\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In contrast, hyperactive JAK2 signaling in PV increases free intracellular Ca2+ levels, which impairs the nuclear export function of CALR (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In mature RBCs from PV patients, high Ca2+ levels increase the activity of the Gárdos channel leading to cell dehydration (111) (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Transmembrane domain (TM), N- and C- termini are indicated. (C) Canonical BAX and BAK dependent pathway of apoptosis and the mechanism through which venetoclax inhibits this pathway. (D) Non-canonical ER Ca2+-dependent pathway of apoptosis and the mechanism through which BIRD-2 inhibits this pathway.4.2 IP3 signaling cascade and Ca2+ release from the ER\nIP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 6\n demonstrates the mutational landscape in lymphoid cancers and \nFigure 7\n in myeloid cancers.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The lymphoid neoplasms reviewed included B-ALL (n = 234-269 patients depending on the gene), DLBCL (n = 1288), low-grade B-cell neoplasms (n= 1542) including CLL (n = 1254), monoclonal B-cell lymphocytosis (n = 54), mantle cell lymphoma (n = 29), plasma cell myeloma (n= 205) and low-grade T-cell neoplasms (n = 43) including Sezary syndrome (n = 26), primary cutaneous CD8/CD30 positive lymphomas (n = 14) and mycosis fungoides (n = 3) (\nFigure 6\n, \nTable 3\n and \nSupplementary Table 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these lymphoid cancers, patients with B-ALL had the lowest frequency of variants in the Ca2+-toolkit encoding genes (5.9%) and patients with low-grade T-cell neoplasms had the highest frequency (48.8%), most carrying multiple variants (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The cBioPortal data did not yet contain results of Bohannan et al. published earlier this year that reported the presence of GRIN2C mutations in high-risk B-ALL patients (145) (\nFigure 3C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Specific genetic variants can be found through these links, all were of unknown significance. *Numbers of patients analyzed and disease groups are clarified in \nTable 3\n.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "AML, acute myeloid leukemia; B-ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; MBL, monoclonal B-cell lymphocytosis; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasms; PCM, plasma cell myeloma.In mature T-cell neoplasms, the most affected genes were those coding for PLC (16.3%), Ca2+/Na+/K+ exchangers (14.0%), TRPC and TRPM channels (11.6% each), CaV and NMDA receptor channels (9.3% each), ryanodine receptors (RYR) (7.0%), and a few others at 4.7% each (TRPV, P2RX, and SERCA) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In mature B-cell neoplasms, mutated genes were broadly similar between the low-grade and high-grade cancers (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In DLBCL, RYR mutations were less common (2.5%) but CACNA variants were more common (3.8%) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RYRs facilitate the release of Ca2+ from the ER in addition to IP3Rs (362) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the group of myeloid neoplasms, we reviewed 821 patients with AML, 151 with MPN and 31-431 patients with myelodysplastic syndrome (MDS) (depending on the gene) (\nFigure 7\n, \nTable 3\n and \nSupplementary Table S3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "It was intriguing that these variants were exclusive with CALR mutations and also appeared exclusive with each other, raising the possibility of their independent effects in MPN (\nFigure 7\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8\n provides a schematic summary of the underlying mechanisms and their consequences in blood cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Understanding how Ca2+ signaling remodels in cancer cells creates therapeutic opportunities, with the potential to spare normal cells and tailor therapies according to the underlying mechanism in different cancers/patients (\nFigure 8\n).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These vesicles contain plasma membrane calcium ATPases (PMCAs) that pump Ca2+ from the cytosol into vesicles and thus protect the cytosolic and membrane proteins from Ca2+-induced damage (oxidation, proteolysis, irreversible dehydration) (see \nFigure 2A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Regulation of Ca2+ concentrations translates into the control over the remodeling of the cytoskeletal elements and concomitant changes in cell shape, cell volume, rheological properties and ultimately, RBC longevity and clearance (52) (\n\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Defective organelle sorting and extrusion from erythroblasts leaves organellar remnants in reticulocytes.Multiple types of channels permeable for Ca2+ are present in the RBC membrane supporting versatility and plasticity of intracellular Ca2+ signaling (53) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "One of the first Ca2+ signaling processes identified in RBCs was the function of the Gárdos channel (potassium calcium-activated channel subfamily N member 4, KCNN4) (63) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Activation of KCNN4 in RBCs of healthy people most likely enables better passage of RBCs through narrow capillaries (70), while its overactivation causes Ca2+-overload and RBC dehydration (71) (\n\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "RBCs from patients with sickle cell disease carry higher numbers of NMDA receptors than in healthy donors (\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In contrast, hyperactive JAK2 signaling in PV increases free intracellular Ca2+ levels, which impairs the nuclear export function of CALR (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In mature RBCs from PV patients, high Ca2+ levels increase the activity of the Gárdos channel leading to cell dehydration (111) (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Transmembrane domain (TM), N- and C- termini are indicated. (C) Canonical BAX and BAK dependent pathway of apoptosis and the mechanism through which venetoclax inhibits this pathway. (D) Non-canonical ER Ca2+-dependent pathway of apoptosis and the mechanism through which BIRD-2 inhibits this pathway.4.2 IP3 signaling cascade and Ca2+ release from the ER\nIP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 6\n demonstrates the mutational landscape in lymphoid cancers and \nFigure 7\n in myeloid cancers.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The lymphoid neoplasms reviewed included B-ALL (n = 234-269 patients depending on the gene), DLBCL (n = 1288), low-grade B-cell neoplasms (n= 1542) including CLL (n = 1254), monoclonal B-cell lymphocytosis (n = 54), mantle cell lymphoma (n = 29), plasma cell myeloma (n= 205) and low-grade T-cell neoplasms (n = 43) including Sezary syndrome (n = 26), primary cutaneous CD8/CD30 positive lymphomas (n = 14) and mycosis fungoides (n = 3) (\nFigure 6\n, \nTable 3\n and \nSupplementary Table 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these lymphoid cancers, patients with B-ALL had the lowest frequency of variants in the Ca2+-toolkit encoding genes (5.9%) and patients with low-grade T-cell neoplasms had the highest frequency (48.8%), most carrying multiple variants (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The cBioPortal data did not yet contain results of Bohannan et al. published earlier this year that reported the presence of GRIN2C mutations in high-risk B-ALL patients (145) (\nFigure 3C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Specific genetic variants can be found through these links, all were of unknown significance. *Numbers of patients analyzed and disease groups are clarified in \nTable 3\n.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "AML, acute myeloid leukemia; B-ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; MBL, monoclonal B-cell lymphocytosis; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasms; PCM, plasma cell myeloma.In mature T-cell neoplasms, the most affected genes were those coding for PLC (16.3%), Ca2+/Na+/K+ exchangers (14.0%), TRPC and TRPM channels (11.6% each), CaV and NMDA receptor channels (9.3% each), ryanodine receptors (RYR) (7.0%), and a few others at 4.7% each (TRPV, P2RX, and SERCA) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In mature B-cell neoplasms, mutated genes were broadly similar between the low-grade and high-grade cancers (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In DLBCL, RYR mutations were less common (2.5%) but CACNA variants were more common (3.8%) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RYRs facilitate the release of Ca2+ from the ER in addition to IP3Rs (362) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the group of myeloid neoplasms, we reviewed 821 patients with AML, 151 with MPN and 31-431 patients with myelodysplastic syndrome (MDS) (depending on the gene) (\nFigure 7\n, \nTable 3\n and \nSupplementary Table S3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "It was intriguing that these variants were exclusive with CALR mutations and also appeared exclusive with each other, raising the possibility of their independent effects in MPN (\nFigure 7\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8\n provides a schematic summary of the underlying mechanisms and their consequences in blood cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Understanding how Ca2+ signaling remodels in cancer cells creates therapeutic opportunities, with the potential to spare normal cells and tailor therapies according to the underlying mechanism in different cancers/patients (\nFigure 8\n).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The collective involvement of these molecules, often referred to as a Ca2+-signaling toolkit (13, 24), is shown in \nFigure 1\n\n(with molecular details described in the figure legend).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Many pathways of cell activation converge on the efflux of Ca2+ from the ER that occurs through channels called inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) (27) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "PLC also generates 1,2-diacylglycerol (DAG) that performs its signaling functions by binding and activating other proteins, including protein kinases C (PKC) and certain transient receptor potential (TRP) canonical (TRPC) channels, in particular TRPC1, that can interact with Orai1 and STIM1 to support SOCE (29, 34) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "ER and mitochondria interact through specialized ER-mitochondrial contact sites called mitochondria-associated ER membranes (MAMs) (36) (\nFigure 1\n, insert a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In analogy to MAMs, mitochondrial membrane contact sites have also been shown to involve lysosomes (50, 51) (\nFigure 1\n, insert b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These vesicles contain plasma membrane calcium ATPases (PMCAs) that pump Ca2+ from the cytosol into vesicles and thus protect the cytosolic and membrane proteins from Ca2+-induced damage (oxidation, proteolysis, irreversible dehydration) (see \nFigure 2A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Regulation of Ca2+ concentrations translates into the control over the remodeling of the cytoskeletal elements and concomitant changes in cell shape, cell volume, rheological properties and ultimately, RBC longevity and clearance (52) (\n\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Defective organelle sorting and extrusion from erythroblasts leaves organellar remnants in reticulocytes.Multiple types of channels permeable for Ca2+ are present in the RBC membrane supporting versatility and plasticity of intracellular Ca2+ signaling (53) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "One of the first Ca2+ signaling processes identified in RBCs was the function of the Gárdos channel (potassium calcium-activated channel subfamily N member 4, KCNN4) (63) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Activation of KCNN4 in RBCs of healthy people most likely enables better passage of RBCs through narrow capillaries (70), while its overactivation causes Ca2+-overload and RBC dehydration (71) (\n\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "RBCs from patients with sickle cell disease carry higher numbers of NMDA receptors than in healthy donors (\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These vesicles contain plasma membrane calcium ATPases (PMCAs) that pump Ca2+ from the cytosol into vesicles and thus protect the cytosolic and membrane proteins from Ca2+-induced damage (oxidation, proteolysis, irreversible dehydration) (see \nFigure 2A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Regulation of Ca2+ concentrations translates into the control over the remodeling of the cytoskeletal elements and concomitant changes in cell shape, cell volume, rheological properties and ultimately, RBC longevity and clearance (52) (\n\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Multiple types of channels permeable for Ca2+ are present in the RBC membrane supporting versatility and plasticity of intracellular Ca2+ signaling (53) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "One of the first Ca2+ signaling processes identified in RBCs was the function of the Gárdos channel (potassium calcium-activated channel subfamily N member 4, KCNN4) (63) (\nFigure 2A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Activation of KCNN4 in RBCs of healthy people most likely enables better passage of RBCs through narrow capillaries (70), while its overactivation causes Ca2+-overload and RBC dehydration (71) (\n\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "RBCs from patients with sickle cell disease carry higher numbers of NMDA receptors than in healthy donors (\nFigure 2A\n\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In contrast, hyperactive JAK2 signaling in PV increases free intracellular Ca2+ levels, which impairs the nuclear export function of CALR (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In mature RBCs from PV patients, high Ca2+ levels increase the activity of the Gárdos channel leading to cell dehydration (111) (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In contrast, hyperactive JAK2 signaling in PV increases free intracellular Ca2+ levels, which impairs the nuclear export function of CALR (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In mature RBCs from PV patients, high Ca2+ levels increase the activity of the Gárdos channel leading to cell dehydration (111) (\nFigure 2B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Transmembrane domain (TM), N- and C- termini are indicated. (C) Canonical BAX and BAK dependent pathway of apoptosis and the mechanism through which venetoclax inhibits this pathway. (D) Non-canonical ER Ca2+-dependent pathway of apoptosis and the mechanism through which BIRD-2 inhibits this pathway.4.2 IP3 signaling cascade and Ca2+ release from the ER\nIP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "These include the non-selective cation channels such as the TRP family, purinoreceptors (P2X7), nicotinic acetylcholine receptor (nAChR), Piezo1, NMDA receptor, and the Ca2+ selective Orai1 channels (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "In non-neuronal cells, including in megakaryocytes, NMDA receptors may also function in a metabotropic-like (i.e. flux independent) manner (97, 98, 180, 181) (see \nFigure 3A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "NMDA receptor exerts these effects by influencing Ca2+ and adenosine diphosphate (ADP) signaling, and the expression of transcripts involved in extracellular matrix remodeling (180) (\nFigure 3B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Instead, obinutuzumab activates intracellular Ca2+ efflux from either lysosomes or the ER into the cytosol (206) (see \nFigure 4A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Manipulation of these interactions may help develop more effective therapeutic combinations for B-cell malignancies (\nFigure 4A\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "4.2 IP3 signaling cascade and Ca2+ release from the ER\nIP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "IP3 is a major regulator of Ca2+ signaling; it binds to IP3Rs on the ER to release Ca2+ into the cytosol (27, 28) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIM, BID, BAX, and BAK) (216) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To overcome Bcl-2 effects in cancer cells, BH3 mimetics like venetoclax were developed that target the hydrophobic BH3-binding groove of Bcl-2 (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Venetoclax binding to Bcl-2 liberates BIM, which activates BAX or BAK, leading to apoptosis (221) (\nFigure 4C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In contrast, a designer peptide Bcl-2 IP3R Disruptor-2 (BIRD-2) targets the BH4 domain of Bcl-2 (224) (\nFigure 4B\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "BIRD-2 binding to Bcl-2 unleashes IP3R activation and cytotoxic Ca2+ levels are released from the ER (155, 225) (\nFigure 4D\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel D",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Plasma membranes are equipped with several isoforms of the plasma membrane calcium ATPases (PMCAs) (241, 242) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Cells also pump Ca2+ out of the cytoplasm into the Golgi apparatus through secretory pathway Ca2+ ATPases (SPCA), and to the ER through SERCA (245) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Inappropriate inhibition of this pathway may contribute to the pathological expansion of megakaryocytes and their precursors, in particular in the context of Down syndrome (313, 314) (see \nFigure 5A\n and the corresponding legend for molecular details).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The mutations in CALR, as well as JAK2 and MPL (\nFigure 5B\n, left), converge to constitutively activate JAK2-STAT signaling, which drives deregulated expansion of HSCs and megakaryocytes (317, 318).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Megakaryocytes with mutated CALR have a decreased association between CALR and STIM1 (\nFigure 5B\n, right), and the CALR type 1 variant has the highest level of dissociation from STIM1.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 6\n demonstrates the mutational landscape in lymphoid cancers and \nFigure 7\n in myeloid cancers.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The lymphoid neoplasms reviewed included B-ALL (n = 234-269 patients depending on the gene), DLBCL (n = 1288), low-grade B-cell neoplasms (n= 1542) including CLL (n = 1254), monoclonal B-cell lymphocytosis (n = 54), mantle cell lymphoma (n = 29), plasma cell myeloma (n= 205) and low-grade T-cell neoplasms (n = 43) including Sezary syndrome (n = 26), primary cutaneous CD8/CD30 positive lymphomas (n = 14) and mycosis fungoides (n = 3) (\nFigure 6\n, \nTable 3\n and \nSupplementary Table 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these lymphoid cancers, patients with B-ALL had the lowest frequency of variants in the Ca2+-toolkit encoding genes (5.9%) and patients with low-grade T-cell neoplasms had the highest frequency (48.8%), most carrying multiple variants (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The cBioPortal data did not yet contain results of Bohannan et al. published earlier this year that reported the presence of GRIN2C mutations in high-risk B-ALL patients (145) (\nFigure 3C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Specific genetic variants can be found through these links, all were of unknown significance. *Numbers of patients analyzed and disease groups are clarified in \nTable 3\n.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "AML, acute myeloid leukemia; B-ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; MBL, monoclonal B-cell lymphocytosis; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasms; PCM, plasma cell myeloma.In mature T-cell neoplasms, the most affected genes were those coding for PLC (16.3%), Ca2+/Na+/K+ exchangers (14.0%), TRPC and TRPM channels (11.6% each), CaV and NMDA receptor channels (9.3% each), ryanodine receptors (RYR) (7.0%), and a few others at 4.7% each (TRPV, P2RX, and SERCA) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In mature B-cell neoplasms, mutated genes were broadly similar between the low-grade and high-grade cancers (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In DLBCL, RYR mutations were less common (2.5%) but CACNA variants were more common (3.8%) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RYRs facilitate the release of Ca2+ from the ER in addition to IP3Rs (362) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the group of myeloid neoplasms, we reviewed 821 patients with AML, 151 with MPN and 31-431 patients with myelodysplastic syndrome (MDS) (depending on the gene) (\nFigure 7\n, \nTable 3\n and \nSupplementary Table S3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "It was intriguing that these variants were exclusive with CALR mutations and also appeared exclusive with each other, raising the possibility of their independent effects in MPN (\nFigure 7\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 6\n demonstrates the mutational landscape in lymphoid cancers and \nFigure 7\n in myeloid cancers.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The lymphoid neoplasms reviewed included B-ALL (n = 234-269 patients depending on the gene), DLBCL (n = 1288), low-grade B-cell neoplasms (n= 1542) including CLL (n = 1254), monoclonal B-cell lymphocytosis (n = 54), mantle cell lymphoma (n = 29), plasma cell myeloma (n= 205) and low-grade T-cell neoplasms (n = 43) including Sezary syndrome (n = 26), primary cutaneous CD8/CD30 positive lymphomas (n = 14) and mycosis fungoides (n = 3) (\nFigure 6\n, \nTable 3\n and \nSupplementary Table 2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these lymphoid cancers, patients with B-ALL had the lowest frequency of variants in the Ca2+-toolkit encoding genes (5.9%) and patients with low-grade T-cell neoplasms had the highest frequency (48.8%), most carrying multiple variants (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The cBioPortal data did not yet contain results of Bohannan et al. published earlier this year that reported the presence of GRIN2C mutations in high-risk B-ALL patients (145) (\nFigure 3C\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "In mature T-cell neoplasms, the most affected genes were those coding for PLC (16.3%), Ca2+/Na+/K+ exchangers (14.0%), TRPC and TRPM channels (11.6% each), CaV and NMDA receptor channels (9.3% each), ryanodine receptors (RYR) (7.0%), and a few others at 4.7% each (TRPV, P2RX, and SERCA) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In mature B-cell neoplasms, mutated genes were broadly similar between the low-grade and high-grade cancers (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In DLBCL, RYR mutations were less common (2.5%) but CACNA variants were more common (3.8%) (\nFigure 6\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RYRs facilitate the release of Ca2+ from the ER in addition to IP3Rs (362) (\nFigure 1\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the group of myeloid neoplasms, we reviewed 821 patients with AML, 151 with MPN and 31-431 patients with myelodysplastic syndrome (MDS) (depending on the gene) (\nFigure 7\n, \nTable 3\n and \nSupplementary Table S3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "It was intriguing that these variants were exclusive with CALR mutations and also appeared exclusive with each other, raising the possibility of their independent effects in MPN (\nFigure 7\n and \nTable 3\n).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8\n provides a schematic summary of the underlying mechanisms and their consequences in blood cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Understanding how Ca2+ signaling remodels in cancer cells creates therapeutic opportunities, with the potential to spare normal cells and tailor therapies according to the underlying mechanism in different cancers/patients (\nFigure 8\n).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 8\n provides a schematic summary of the underlying mechanisms and their consequences in blood cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Understanding how Ca2+ signaling remodels in cancer cells creates therapeutic opportunities, with the potential to spare normal cells and tailor therapies according to the underlying mechanism in different cancers/patients (\nFigure 8\n).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  }
]